These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2451361)

  • 1. Acute cerebral and peripheral circulation disorders.
    Klein K; Klein M
    Z Alternsforsch; 1988; 43(1):3-9. PubMed ID: 2451361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E; Kollar L; Matrai A
    Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of intravascular volume expansion without hemodilution to elevate cortical blood flow in region of experimental focal ischemia.
    Wood JH; Snyder LL; Simeone FA
    J Neurosurg; 1982 Jan; 56(1):80-91. PubMed ID: 7054423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
    Brehme S; Keysser G; Turowski A; Schmidt HH
    Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of low and high molecular weight dextrans on selected serum lipid parameters. 1].
    Rühlmann C; Koksch M; Kuklinski B
    Z Gesamte Inn Med; 1992 Jan; 47(1):6-11. PubMed ID: 1373926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microcirculatory, hemorheologic and microcirculatory parameters before and following hypervolemic hemodilution in patients with acute cerebrovascular disorders].
    Staedt U; Kortsik C; Seufzer U; Lessenich A; Hütt M; Keller H
    Vasa Suppl; 1989; 27():33-4. PubMed ID: 2482989
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on isovolemic hemodilution in acute ischemic stroke.
    Comes L; Mureşan A; Costin Z
    Rom J Intern Med; 1996; 34(1-2):43-7. PubMed ID: 8908629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative therapy of peripheral arterial occlusive diseases].
    Alexander K
    Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of moderate normovolemic hemodilution on changes in systemic hemodynamics during complex treatment of ischemic stroke patients].
    Komorovskaia IIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1172-6. PubMed ID: 6171961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodilution and brain protection?].
    von Bormann B; Weiler J; Wirtz S; Aulich S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(2 Suppl):S264-8. PubMed ID: 9417242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hydroxyethyl starch and dextran on metabolism of extremity muscles in patients with arterial occlusive disease].
    Stark G; Tischler R; Decrinis M; Lafer M; Obernosterer A; Pieber D; Pilger E
    Vasa Suppl; 1991; 33():171. PubMed ID: 1724099
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cerebral ischemia by hemodilution.
    Hossmann KA; van den Kerckhoff W; Matsuoka Y
    Bibl Haematol; 1981; (47):77-85. PubMed ID: 7188581
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of crystalloids and colloids for hemodilution in a model of focal cerebral ischemia.
    Korosue K; Heros RC; Ogilvy CS; Hyodo A; Tu YK; Graichen R
    J Neurosurg; 1990 Oct; 73(4):576-84. PubMed ID: 1697903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations during hypervolemic hemodilution of patients with acute focal cerebral ischemia.
    Wood JH; Fleischer AS
    JAMA; 1982 Dec; 248(22):2999-304. PubMed ID: 7143673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Considerations in hemodilution therapy of stroke].
    Oder W; Kollegger H; Zeiler K; Deecke L
    Acta Med Austriaca; 1989; 16(5):109-14. PubMed ID: 2483488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.